Neko Health, the preventive healthcare company co-founded by Spotify's Daniel Ek and Hjalmar Nilsonne, has announced its expansion into the United States. The company's first clinic is set to open on September 24 in New York City's SoHo neighborhood, addressing a waitlist of over 25,000 local residents. This launch marks a significant step in Neko Health's mission to provide proactive and data-driven health assessments to a wider audience.
A New Approach to Preventive Healthcare
The company's core offering is the Neko Health Scan, a comprehensive 60-minute assessment priced at $499. This non-invasive and radiation-free procedure gathers millions of data points related to heart, blood, skin, and metabolic health. The goal is to give individuals a detailed understanding of their current health status before symptoms of illness arise.
Following the scan, members receive their results during the same visit, a notable departure from traditional healthcare timelines. A clinician then reviews the data with the member, providing actionable insights and a personalized plan for the future. This immediate feedback loop is designed to empower individuals to take control of their long-term well-being.
Significant Financial Backing and High Demand
Neko Health's U.S. debut is supported by a recent $700 million Series C funding round. The investment was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners, signaling strong investor confidence. This substantial capital injection will fuel the company's ambitious expansion plans across the country and further technology development.
The funding round also attracted a roster of prominent individual investors, including Mark Zuckerberg, Priscilla Chan, and Maria Sharapova. This high-profile backing corresponds with immense public interest, evidenced by a global waitlist of over 350,000 people. In its existing markets in the UK and Sweden, the company has already performed over 100,000 scans.
Strategic Expansion Across the United States
The inaugural U.S. clinic is located at 300 Lafayette Street, a two-floor facility in the heart of SoHo. It will house seven scan rooms and feature Neko's signature design, which aims to create a welcoming and modern healthcare environment. The space is intended to reflect the company's innovative approach, moving away from the typical clinical setting.
CEO Hjalmar Nilsonne stated that New York was a natural first choice for the U.S. launch, citing the city's high standards. Following the SoHo opening, Neko Health plans to establish additional locations throughout New York City. The company's roadmap then includes sequential openings in Miami, Washington D.C., and San Francisco over the next year.
Neko Health's entry into the American market represents a significant development in the preventive care sector. By combining advanced scanning technology, substantial venture capital, and a direct-to-consumer model, the company is poised to challenge traditional healthcare paradigms. With a clear strategy for national expansion, Neko Health aims to make proactive health management more accessible and data-informed for U.S. consumers.